LIPIDOR AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.24 SEK | +4.35% |
|
+1.69% | -52.38% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Lipidor AB is a Sweden-based drug delivery company focusing on topical medication. The Company is focused to develop, patent and commercialize formulation concepts and technologies based on lipids. The Company develops product concepts based on AKVANO technology, which represents a dosage form that creates a lipid layer on the skin surface for effective delivery of drugs and skin care treatment. The Companyâs cooperation partners include Cerbios-Pharma, which specializes in the development and manufacturing of chemical and biological active pharmaceutical ingredients (APIs), and Aurena Laboratories AB, a manufacturer of bag-on-valve aerosol sprays for the pharmaceutical and medical device industry.
Sector
Pharmaceuticals
Calendar
2024-05-22
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -52.38% | 611K | |
| +26.03% | 653B | |
| +27.00% | 556B | |
| -6.59% | 354B | |
| +20.29% | 331B | |
| +3.79% | 296B | |
| +12.90% | 233B | |
| +5.55% | 201B | |
| -9.57% | 193B | |
| -6.44% | 144B |
- Stock Market
- Equities
- LIPI Stock
- News Lipidor AB
- Lipidor : Signs Exclusive Licensing Agreement with Cannassure Therapeutics
